Steadi-3 Plus

Stabilise Your Hands. Reclaim Your Freedom.

The Steadi-3 Plus is a revolutionary assistive device that reduces hand tremor. It is based on proven magnetic vibration absorber technology to stabilise buildings against earthquakes.4 Like a see-saw you’d see in a park, the vibration disk moves in the opposite direction to your tremor, providing stability.

 

The Steadi-3 Plus is a battery-free anti tremor glove using passive magnetic stabilisation to counteract tremor without charging, electronics, or setup. It is designed for Essential Tremor and the action-tremor component of Parkinson’s Disease. As a wearable tremor device, it has been clinically evaluated: 84% of users in a placebo-controlled study showed improved tremor control versus no device, and 70% showed improvement over a placebo hand tremor glove based on blinded neurologist assessments.1,2 It is a TGA listed medical device, available without a prescription.9

Steadi 3

        Overview

What is Steadi-3 Plus?

The Steadi-3 Plus is a lightweight assistive device worn on the back of the hand. It uses the same idea as the dampers that steady tall buildings: a mass inside moves opposite to your tremor and absorbs it. Attracting magnets let it retune itself as your hand moves, so there is nothing to charge, set or calibrate.4

 

Not all gloves for tremors use the same mechanism. The Steadi-3 Plus is a purpose-built essential tremor glove: instead of relying on weight alone, it uses passive magnetic stabilisation to counteract tremor motion, with no batteries and no charging. A healthcare provider can help determine whether it is appropriate.

Battery-Free

Battery-free, powered by movement for all-day comfort.

Effective

80% of participants improved versus no device in our blinded study.1,2

Ultra-lightweight design

The lightest tremor glove available on the market, 300 grams.
Steadi 3

How it works

Steadi-3 PlusTechnology Explained

The Steadi-3 Plus is a Class I medical device that supports people with Essential Tremor or Parkinson’s Disease tremors.Using advanced tremor glove technology, this hand stabiliser device improves control and independence, offering an effective Essential Tremor solution.

Borrowed from earthquake engineering

 

A tall building is steadied by a tuned mass damper: a heavy mass that moves out of step with the building and absorbs its sway. A building sways at one frequency, so one spring is enough. Tremor moves: it changes between people, and within one person with fatigue, medication and the task.

Lab test, November 2025: on an instrumented test rig, the device absorbed 2 to 3 times more vibration than the same weight added passively, and added no new frequencies.4 A test rig is not a hand, so this shows how the mechanism works, not how much a person’s tremor will drop.

Clinical Evidence

Neurologist-rated tremor reduction across everyday tasks

These figures come from small studies (9 and 12 people) designed and funded by Steadiwear.1,2 The first two describe how many participants improved, not how much tremor was removed. Results vary from person to person.

8 in 10

vs no device

Participants with a lower (better) tremor severity rating from a blinded neurologist when wearing the device than when wearing nothing. Blinded study, 9 adults with Essential Tremor.2,6

7 in 10

vs weighted placebo

Compared with a placebo device of identical look and weight, worn by the same participants. This controls for the effect of added weight and expectation.2

43%

lower severity vs no device

Average fall in clinician-rated tremor severity across three tasks. Against the weighted placebo, the average fall was 29%.2

83%

after one week at home

Participants in a separate one-week follow-up (12 people) who reported significant improvement, with no adverse events. Self-reported, with no comparison group.1

The same spiral, minutes apart

The Archimedes spiral is one of the three tasks scored blind in the study. These proof-of-concept tracings come from one person with moderate to severe Essential Tremor.
How the study was run
Nine adults with Essential Tremor did three tasks (drinking from a cup, finger to nose, and drawing an Archimedes spiral) under three conditions, in random order:

  1. No device.
  2. A weighted placebo device of identical appearance, with no active mechanism.
  3. The Steadi-3.Blinding
    Recordings were masked, then scored blind by a neurologist on a modified Fahn-Tolosa-Marín scale. The scorer did not know which condition they were watching.

Funding
The study was designed, run and funded by Steadiwear Inc. (internal report, February 2025, available on request). Read the results with that in mind.2

Without the device

With the Steadi-3

Post-market survey, 62 users

What users report in daily life

Users rated how hard eight everyday tasks were before and while using the device. Whole-hand tasks responded most: writing, pouring, eating and drinking. Fine finger tasks like buttoning responded least.3

These are estimates converted from self-reported difficulty, not measured tremor, and the survey has no comparison group. In a survey of users, people who chose to keep the device reported an estimated average tremor reduction of 44%. People who returned it reported almost no change.3

1. Steadiwear Inc. Steadi-3 Validation Study. Data on file. Improvement defined as a lower neurologist-rated modified FTM score in at least one of three tasks.
2. Relative reduction in mean score versus no intervention, calculated from reported means.

Bench Testing

On an instrumented six-degree-of-freedom test rig (November 2025), the Steadi-3 Plus reduced transmitted movement by 52% or more across the tremor range, and by 2 to 3 times more than the same weight added passively. Frequency analysis confirmed it adds no new vibration frequencies.4 A test rig is not a hand, so these figures show how the mechanism works, not how much a person’s tremor will drop.

Independent study of the earlier Steadi-1

Independent investigators with no financial tie to Steadiwear tested the earlier Steadi-1 in 20 adults with Essential Tremor, against a weight-matched 550 g sham glove. Measured acceleration was lower with the device than with the sham in three of four tasks, and significantly lower on spiral drawing. The results were presented at the 2026 International Congress of Parkinson’s Disease and Movement Disorders; the full paper is pending.5

Safety

No adverse events were reported in the one-week follow-up.1 The device is validated for up to 16 hours of continuous daily wear.10 It has no battery, electronics or skin stimulation. It contains permanent magnets and carries labelling for magnetic fields and MRI, so people with an implanted medical device should talk to their healthcare provider first.10

Limitations of this evidence

  1. No randomised controlled trial yet. The controlled studies are small crossover evaluations (9 and 20 people).2,5
  2. No head-to-head comparison with any other tremor device.
  3. The evidence is mostly in Essential Tremor. Parkinson’s Disease is represented by 5 survey respondents and no controlled data.3
  4. Three of the four datasets were designed, run or funded by Steadiwear.1
  5. The survey is self-reported and unblinded, and its amplitude figures are estimates.3
  6. About 2 in 10 participants did not improve compared with no device, and 3 in 10 compared with the placebo.2
  7. Durability beyond one year of wear is not yet characterised.1,10

How these results compare to other tremor devices

The peer-reviewed literature on wearable mechanical tremor devices is small but growing. Two reviews provide useful comparative context.

2021

Lora-Millán et al. reviewed 41 studies of wearable tremor suppression technologies — weighted, gyroscopic, and tuned mass damper devices. Tremor amplitude reductions ranged from approximately 20% to 80%, varying by technology, tremor type, and measurement method.7

2024

Mo & Priefer reviewed peripheral devices and mechanical strategies for Essential Tremor, concluding that mechanical dampening shows clinical promise but that larger randomised trials are needed across the device category.8

The Cala Trio, a prescription device in the USA, has been tested in published randomised trials.11 No study has yet compared it directly with the Steadi-3 Plus, so the two can’t be ranked against each other.10

Evidence in progress

  • A real-world outcomes manuscript is under revision at Tremor and Other Hyperkinetic Movements.3
  • The full paper from the independent Steadi-1 study is pending.5
  • A multi-hospital clinical study is under way in Turkey, covering Essential Tremor and Parkinson’s Disease.1
  • A three-year post-market durability survey is planned.1

Patient selection

Is Steadi-3 Plus right for your patient?

The response is strongest on whole-limb tasks and weakest on fine finger tasks.3 That gradient is the selection rule.

Most likely to benefit

  • Difficulty with cups, cutlery, pouring or signing
  • Action or postural tremor of Essential Tremor or Parkinson’s
  • Partial response to medication, or intolerance of it
  • Patients who can’t predict when they’ll need a steady hand
  • Declined surgery, or not a surgical candidate
  • Both hands involved

Less likely to benefit

  • Primary complaint is buttons, zips, keys or small screens
  • Wrist pathology or proximal weakness: 300 g may not suit
  • Tremor outside roughly 4 to 8 Hz10
  • Patient won’t accept a visible device on the wrist
  • Expecting the tremor to be eliminated rather than reduced

Response can vary with medication timing, sleep, stress and exercise.

Assessing a patient in clinic

 

Pick the task, then baseline it

    • Ask which everyday task the patient finds hardest. Pouring a glass of water and signing a name are the highest-yield. Have them do it without the device while you watch.

Fit the device and repeat

    • Fit it correctly: a loose or badly positioned unit underperforms. Repeat the same task within a minute. The effect is immediate.

Read the result

    • A positive assessment is visible steadying within seconds. Little or no change on repeat means that patient is better served elsewhere, and you know it in the room.

At a glance

Mechanism Passive tuned mass damping with proprietary magnetic spring system
Power None required – battery-free, no electronics
Weight Approx. 300 g
Modes Standard and Enhanced
Sizing Small: hand circumference 22.9 cm or less · Large: over 22.9 cm
Configuration Left hand, right hand, or pair
Materials Silicone and neoprene foam strap; detachable stabiliser
Warranty 12 months
Regulatory
ARTG No. 531390

Testimonials

Real People. Real Stability.

Discover how Steadi-3 Plus helps users regain confidence and control in their daily lives.

Medication didn’t help, but Steadi-3 Plus did! It makes daily tasks easier and gives me a relaxed, confident feeling. Worth every penny!
Katherine Kowpack

Essential Tremor affects my daily life-writing, eating, even drinking. With Steadi-3 Plus, I feel more confident, in control, and no more spills on my shirt! I’d 100% urge anyone with Essential Tremor to give this a try!
Joel Greenspan

I’ve had Essential Tremor for years, but Steadi-3 Plus changed everything! It steadies my hand, lets me write again, and even helps me cook safely. It truly gives me my life back!
Betty Faulkner

Testimonials are from Steadiwear users and reflect individual experiences. Results may vary.

Resources

Clinical resources

Clinician product overview

Patient information leaflet

Instructions for Use

Fitting and demonstration video

Listen and learn

ReachMD NeuroFrontiers podcast

Dr Jerome Lisk speaks with Steadiwear’s co-founders about the engineering and early evidence.

Living with hand tremor?

Steadi-3 Plus is available to buy through Aurora Direct.

FAQs

Clinician FAQs

Is the Steadi-3 Plus clinically proven?
We don’t use that term: no single small study proves a device works for everyone. In a blinded, placebo-controlled study of 9 people, 8 in 10 improved compared with no device and 7 in 10 compared with a weighted placebo.1,2 Larger studies are under way.
Why isn't the study published yet?
The blinded evaluation is complete and documented in an internal report. A real-world outcomes manuscript is under revision at Tremor and Other Hyperkinetic Movements, and a multi-hospital study is running in Turkey.1,3
What is the sample size?
Nine people in the blinded, placebo-controlled study, 12 in the one-week follow-up and 62 in the post-market survey. An independent study of the earlier Steadi-1 included 20 people.1,2,3,5
Can it be used alongside medication?
Yes. Steadi-3 Plus is non-pharmacological and can be used alongside a patient’s existing treatment plan.
How do patients purchase Steadi-3 Plus?
Patients can buy directly through Aurora Direct, www.auroradirect.com.au. Clinicians and practices can contact Aurora BioScience for more information on info@aurorabioscience.com.au
Was the study funded by Steadiwear?
Yes. Three of the four datasets were designed, run or funded by Steadiwear.1 The fourth, a study of the earlier Steadi-1, was run by independent investigators.5

Sources

  1. Steadiwear Inc. Clinical Evidence Summary, STDW-CES-001 Rev 01, 13 October 2026.
  2. Steadiwear Inc. Blinded placebo-controlled performance evaluation of the Steadi-3. Internal report, February 2025. Available on request.
  3. Steadiwear Inc. Post-market activity-difficulty survey, N = 62. Manuscript under revision, Tremor and Other Hyperkinetic Movements.
  4. Steadiwear Inc. Six-degree-of-freedom bench validation report, November 2025. Available on request.
  5. Shi RB, Rizek P. Clinical and kinematic evaluation of a tremor-damping glove in essential tremor. Mov Disord. 2026;41(suppl 1).
  6. Fahn S, Tolosa E, Marín C. Clinical Rating Scale for Tremor. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 1988:225–234.
  7. Lora-Millán JS, Hidalgo AF, Rocon E. A Review on Wearable Technologies for Tremor Suppression. Frontiers in Neurology. 2021.
  8. Mo J, Priefer R. Shaking Up Essential Tremor: Peripheral Devices and Mechanical Strategies to Reduce Tremor. Tremor and Other Hyperkinetic Movements. 2024.
  9. Therapeutic Goods Administration. Australian Register of Therapeutic Goods, ARTG entry 531390 (Steadi-3 Plus).
  10. Steadiwear Inc. Clinical evidence. steadiwear.com/pages/clinical-evidence (accessed 4 November 2026).
  11. Pahwa R, Dhall R, Ostrem J, et al. An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor. Neuromodulation. 2019;22(5).